NephroPlus FY26 Revenue Up 32% to ₹999 Crore

NephroPlus reported FY26 revenue of ₹998.8 crore, a 32.2% YoY growth driven by 16.6% treatment volume increase and higher international contribution.
Adjusted EBITDA grew 37.6% to ₹238.1 crore with ROCE improving to 22.8%, supported by scalable operations and cost discipline.
The company expanded to 520+ clinics across 325+ cities serving 36,000+ patients, maintaining 50%+ market share in India's organized dialysis market.
Management outlined growth strategy focusing on India presence deepening, international scaling, and digital innovation through Reformmed.AI platform.